Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Li Auto Inc (LI) vs Koninklijke Philips NV (PHG) Price & Performance

Li Auto IncTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Li Auto Inc vs Koninklijke Philips NV — how do they compare? Li Auto Inc trades at $11.54 (market cap $10.71B), while Koninklijke Philips NV trades at $24.24 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 2.2× Li Auto Inc's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Li Auto Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Li Auto Inc for 101 Days and Koninklijke Philips NV for 84 Days on average.

LIPHG
Market Cap
$10.71B$23.52B
Volume
1,781,1431,635,069
Sector
Consumer CyclicalHealth
52-Week High
$23.13$32.91
52-Week Low
$10.69$23.81
Typical Hold Time
101 Days84 Days
Enterprise Value
$139.58M$29.87B
Dividend Yield
—4.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Li Auto Inc

Li Auto (LI) trades at $10.90, down 0.82% and near 52-week lows, reflecting bearish technical signals and recent earnings misses. The company reported declining revenue ($112.31B in 2025) and negative net income margins (-4.4%), though valuation metrics like P/S (0.73) appear attractive. Recent news highlights delivery moderation and new model launches (Li i9, Li MEGA) amid intense EV competition.

The stock faces near-term headwinds from cash burn and competitive pressures, but analyst consensus remains cautiously optimistic with a $15.18 price target. Key risks include execution challenges in global expansion and margin recovery, while potential upside hinges on successful product cycles and cost management improvements.

Koninklijke Philips NV

PHG trades at $24.30, up 0.87% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong cash flow generation. Recent news highlights product innovations including new CT systems and AI healthcare advancements, while institutional ownership shows mixed activity.

The outlook remains cautious with analyst consensus at Hold (63.64%) despite positive earnings momentum. Key risks include cybersecurity threats and competitive pressures in health technology. The stock presents a recovery opportunity but requires monitoring of execution risks and market sentiment shifts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LI
50% Buy50% Sell
Avg holding period · 101 Days
PHG

No sentiment data available yet.

About Li Auto Inc

Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.

Read more on LI →

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG →